Delivery Order SPE2DR25D6044-SPE2DR26FYA2T
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,861.20 to AmerisourceBergen Drug Corp for Tri-Lo-Estarylla Tablet 28s, a hormonal contraceptive medication. This firm fixed-price delivery order, issued on September 29, 2025, with a completion date of September 30, 2025, represents a non-competitive set-aside contract supporting the military's pharmaceutical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $12,314.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21 count packages) on September 24, 2025, with an ultimate completion date of September 25, 2025. This non-set-aside competitive award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1-20 Tablet 21s, a contraceptive medication, valued at $10,234.79 with a firm fixed price contract type. The award was issued on September 19, 2025, with an ultimate completion date of September 22, 2025, and represents a non-competitive delivery order. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $3,336.32 to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21-tablet supply) on July 31, 2025, with ultimate completion by August 1, 2025. This is a firm fixed price, non-set-aside delivery order supporting federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,816.41 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1.5-30 tablets (21-count package). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a $13,027.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28s, a hormonal contraceptive medication. This is a non-set-aside competitive award with performance to be completed by November 10, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,121.57 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,291.19 on September 26, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of Loestrin 21 1-20 tablets (a contraceptive medication) in quantities of 21 tablets per unit. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, was competitively awarded without set-aside restrictions. The contract represents a...
- The Defense Logistics Agency awarded a $24,256.99 firm fixed price delivery order to AmerisourceBergen Drug Corp for Loestrin 21 1-20 tablets (quantity 21s), with an ultimate completion date of December 9, 2025. This non-set-aside contract was competitively awarded and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $3,500.57 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor, with performance taking place at its corporate office...
- SPE2DR25D6044Indefinite Delivery Contract
- SPE2DR25D6044-SPE2DR26FYA2TDelivery Order
The Defense Logistics Agency awarded a $1,023.70 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for Tri-Lo-Estarylla Tablet 28s, a hormonal contraceptive medication. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with completion expected by December 4, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies the military and veteran healthcare systems through the DLA Medical Supply Chain. The company has demonstrated extensive capability in providing diverse pharmaceutical products and medical supplies through competitive awards with firm fixed pricing structures. This delivery order is part of AmerisourceBergen's broader pharmaceutical support mission, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/2/25 |